Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?

Author： Stephan A.   Masri M.A.   Barbari A.   Kamel G.   Karam A.   Kilani H.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.33, Iss.5, 2001-08, pp. : 2778-2779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: is it justified?

By Sumethkul V.   Ingsathit A.   Leelasa-Nguan P.   Jirasiritham S.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3217-3219

Elsevier

Access to resources Recommend Favorite

Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients

By Budde K.   Glander P.   Braun K.P.   Bohler T.   Waiser J.   Fritsche L.   Mai I.   Neumayer H.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3313-3315

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil

By Becker B.N.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2777-2778

Elsevier

Access to resources Recommend Favorite

Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients

By Budde K.   Braun K.-P.   Glander P.   Bohler T.   Hambach P.   Fritsche L.   Waiser J.   Mai I.   Neumayer H.-H.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1748-1750

Elsevier

Access to resources Recommend Favorite

Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation

By Grasser B.   Iberer F.   Schaffellner S.   Kniepeiss D.   Stauber R.   Koshsorur G.   Rehak P.   Tscheliessnigg K.H.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2154-2156

Elsevier

Access to resources Recommend Favorite